-
Even Trump Can't Save Twitter From Monetization Failure
Monday, May 1, 2017 - 11:48am | 412Read More...Twitter Inc (NYSE: TWTR) investors enjoyed a big post-earnings pop last week, and shares are surging another 6.5 percent on Monday after the company disclosed that CEO Jack Dorsey purchased more than half a million shares of the stock. However, a surprise uptick in user numbers in the first quarter...
-
Analyst Sees Eli Lilly Fairly Valued At $81 Per Share, Downgrades To Hold
Thursday, April 27, 2017 - 10:06am | 363Read More...Argus analyst Katelyn Bayone believes shares of Eli Lilly and Co (NYSE: LLY) are fairly valued at around $81, which prompted her to downgrade the stock from Buy to Hold. According to Bayone, shares are trading near their 52-week high and also at a superior valuation versus its peers. In fact, the...
-
McDonald's Turnaround Efforts, Growth Prospects Lead To Upgrade
Thursday, April 27, 2017 - 9:22am | 353Read More...McDonald's Corporation (NYSE: MCD) won over a Wall Street analyst after its earnings report, as Argus' John Staszak upgraded the stock from Hold to Buy with a newly established $158 price target given the fast food chain's turnaround efforts and growth prospects. McDonald's 2017...
-
Verizon's Place As A High-End Provider Could Be In Jeopardy
Friday, April 21, 2017 - 8:10am | 370Read More...Verizon Communications Inc. (NYSE: VZ)'s status as being a premium-priced and higher-end "Tiffany network" is now being called into question after the company's first quarter earnings report. According to Argus' Joseph Bonner, Verizon's "weak" earnings report...
-
A Peek Into The Markets: U.S. Stock Futures Edge Higher; GE Profit Beats Views
Friday, April 21, 2017 - 7:40am | 400Read More...Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade. Minneapolis Federal Reserve Bank President Neel Kashkari is set to speak in St. Paul, Minn. at 9:30 a.m. ET. The flash Composite PMI for April is schedule for release at 9:45 a.m. ET, while data on existing home...
-
Investors May Have Just Found A Good Entry Point In Fastenal
Tuesday, April 18, 2017 - 2:49pm | 347Read More...John Eade of Argus upgraded shares of Fastenal Company (NASDAQ: FAST) from Hold to Buy with a $54 price target after patiently waiting on the sidelines for a good entry point. Eade commented in a research report Tuesday that Fastenal's first-quarter earnings report and its subsequent 10-percent...
-
Nvidia-Google Blog Beef: Here's What You Need To Know
Monday, April 17, 2017 - 9:04am | 362Read More...The latest feud isn't pitting two Hollywood celebrates against each other, rather two high profiled tech executives. NVIDIA Corporation (NASDAQ: NVDA)'s CEO Jen-Hsuan Huang published a dual-purpose blog post: First, document the company's advances in artificial intelligence (AI), and second, refute...
-
Despite Record Q1 Deliveries, Some Investors Still Question Tesla's 'Inconsistent' Operational Performance
Tuesday, April 11, 2017 - 11:09am | 355Read More...Not all analysts are hunky dory about Tesla Inc (NASDAQ: TSLA). Even as Tesla recently received an upgrade from Piper Jaffray, one analyst is cautious about its spending spree, at least in the near to medium term. Argus said in a note released Tuesday it is concerned about Tesla's inconsistent...
-
AT&T Lands Deal To Develop First Responder Broadband Network
Friday, April 7, 2017 - 10:26am | 492Read More...AT&T Inc. (NYSE: T) announced it has entered into an agreement with the federal First Responder Network Authority (FirstNet) “to build and operate a dedicated national wireless broadband network for police, firefighters and emergency medical services,” Argus’ Joseph Bonner...
-
Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy
Thursday, April 6, 2017 - 1:08pm | 365Read More...Argus' Stephen Biggar initiated coverage of Sanofi SA (ADR) (NYSE: SNY) with a Buy rating and $50 price target as the company has moved past a challenging period. According to Biggar, Sanofi has suffered through a period in which two of its best selling drugs, Lantus (diabetes) and Plavix (...
-
Argus Upgrades Wynn Resorts To Buy, Praises The Wynn Palace In Macau
Wednesday, April 5, 2017 - 8:26am | 284Read More..."Despite stiff competition, results at the Wynn Palace in Macau, which opened in August 2016, have shown consistent improvement, with occupancy and room rates both rising in the fourth quarter,” Argus’ John Staszak said in a note. The analyst upgraded the rating on Wynn Resorts,...
-
Nike Gets Its First Downgrade Of 2017
Tuesday, April 4, 2017 - 8:16am | 342Read More...Nike Inc (NYSE: NKE) reported its fiscal 2017's third-quarter EPS ahead of expectations. The company’s revenue and EPS growth will likely decelerate over the next 12 months due to competition, Argus’s John Staszak said in a report. Citing elevated levels of international inventories and...
-
Snap Shares Are Priced For Flawless Execution
Monday, April 3, 2017 - 8:57am | 327Read More...Although Snap Inc (NYSE: SNAP) is among the fastest-growing social media platforms, its daily active user growth has slowed due to stiff competition, Argus’s Jim Kelleher said in a report. While mentioning that the Street’s revenue estimates appeared aggressive, the analyst suggested...
-
Argus Initiates Bioverativ With Hold
Friday, March 31, 2017 - 10:43am | 286Read More...In February, Bioverativ Inc (NASDAQ: BIVV) spun off from Biogen Inc (NASDAQ: BIIB) with two marketed products for the treatment of hemophilia. While expressing optimism regarding Bioverativ being able to establish itself as a “profitable, independent biotechnology company” that is...
-
Anthem Non-Renewal Still A Huge Risk For Express Scripts
Tuesday, March 28, 2017 - 10:12am | 352Read More...Express Scripts Holding Company (NASDAQ: ESRX) reported robust fourth-quarter 2016 results. There are concerns, however, regarding Express Scripts’ customers wanting to lower prices at the time of contract renewal and the risk that the company’s largest customer Anthem Inc (NYSE: ANTM)...















